Search results for "Trauma"
Adding vancomycin to cefazolin didn't reduce infections among arthroplasty patients
Cefazolin plus vancomycin did not lead to lower surgical-site infection rates compared with cefazolin plus placebo in patients getting knee, hip, or shoulder replacement surgery, a randomized trial in Australia found.
https://acphospitalist.acponline.org/archives/2023/10/25/free/adding-vancomycin-to-cefazolin-didnt-reduce-infections-among-arthroplasty-patients.htm
25 Oct 2023
No sedation, light sedation associated with similar outcomes in ventilated ICU patients
Mortality within 90 days and time spent in the ICU or on mechanical ventilation were similar whether patients were randomized to no sedation or light sedation with a daily interruption.
https://acphospitalist.acponline.org/weekly/archives/2020/02/26/3.htm
26 Feb 2020
Job switching, recruiting, and more
This issue includes advice on searching for a job during the pandemic and hiring NPs and PAs, a call to action against racism, and clinical coverage of perioperative risk and AKI in cirrhosis.
https://acphospitalist.acponline.org/archives/2021/03/letter-from-the-editor.htm
15 Mar 2021
Nutrition, contrast and AKI, and more
Research summaries from ACP Hospitalist Weekly.
https://acphospitalist.acponline.org/archives/2020/09/recent-research.htm
15 Sep 2020
Data but few answers on vasopressors
An expert reviews the evidence on mean arterial pressure targets and various vasopressors.
https://acphospitalist.acponline.org/archives/2020/04/data-but-few-answers-on-vasopressors.htm
15 Apr 2020
Cardiac societies release guideline on evaluation, diagnosis of chest pain
The recommendations from the American Heart Association and the American College of Cardiology, with support from other societies, provide algorithms for assessing and diagnosing chest pain in adults and offer 10 take-home points, including on use of testing and imaging.
https://acphospitalist.acponline.org/weekly/archives/2021/11/10/3.htm
10 Nov 2021
New antibiotic approved for hospital-acquired pneumonia
The FDA approved sulbactam and durlobactam for injection to treat hospital-acquired or ventilator-associated pneumonia caused by susceptible strains of Acinetobacter baumannii-calcoaceticus complex, among other recent actions.
https://acphospitalist.acponline.org/archives/2023/07/05/new-antibiotic-approved-for-hospital-acquired-pneumonia.htm
5 Jul 2023
Earlier renal replacement therapy didn't provide benefit for patients with sepsis and AKI
The trial was stopped for futility after it found that providing renal replacement therapy within 12 hours of documented severe acute kidney injury (AKI) did not reduce 90-day mortality.
https://acphospitalist.acponline.org/weekly/archives/2018/10/17/4.htm
17 Oct 2018
New rules for diagnosis
Experts propose diagnostic competencies and principles.
https://acphospitalist.acponline.org/archives/2019/01/new-rules-for-diagnosis.htm
15 Jan 2019
Intermittent multidrug IV therapy potentially useful in refractory Mycobacterium abscessus pulmonary disease
In a small study of 36 patients in South Korea, 62% and 12% of those with M. abscessus disease and 80% and 60% of those with M. massiliense disease had at least one negative culture and culture conversion, respectively.
https://acphospitalist.acponline.org/archives/2023/09/13/intermittent-multidrug-iv-therapy-potentially-useful-in-refractory-mycobacterium-abscessus-pulmonary-disease.htm
13 Sep 2023